InvestorsHub Logo
Followers 146
Posts 11444
Boards Moderated 0
Alias Born 04/29/2012

Re: docsetc post# 23927

Wednesday, 04/21/2021 10:31:24 AM

Wednesday, April 21, 2021 10:31:24 AM

Post# of 26257

They are constantly in initial test-mode and their antibody research and related patents are so far behind Gilead, ENZC, and Merck, that they won't be catching up for a profitable market release.



Halberd has always been in test mode. They test a scam and if it sells stock they run with that till is falters and then they test the next scam to sell stock.